171 related articles for article (PubMed ID: 27648075)
21. Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses.
Barberini DJ; Aleman M; Aristizabal F; Spriet M; Clark KC; Walker NJ; Galuppo LD; Amorim RM; Woolard KD; Borjesson DL
Stem Cell Res Ther; 2018 Apr; 9(1):96. PubMed ID: 29631634
[TBL] [Abstract][Full Text] [Related]
22. Equine allogeneic umbilical cord blood derived mesenchymal stromal cells reduce synovial fluid nucleated cell count and induce mild self-limiting inflammation when evaluated in an lipopolysaccharide induced synovitis model.
Williams LB; Koenig JB; Black B; Gibson TW; Sharif S; Koch TG
Equine Vet J; 2016 Sep; 48(5):619-25. PubMed ID: 26114736
[TBL] [Abstract][Full Text] [Related]
23. Blood type and breed-associated differences in cell marker expression on equine bone marrow-derived mesenchymal stem cells including major histocompatibility complex class II antigen expression.
Kamm JL; Parlane NA; Riley CB; Gee EK; Dittmer KE; McIlwraith CW
PLoS One; 2019; 14(11):e0225161. PubMed ID: 31747418
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury.
Takahashi A; Nakajima H; Uchida K; Takeura N; Honjoh K; Watanabe S; Kitade M; Kokubo Y; Johnson WEB; Matsumine A
Cell Transplant; 2018 Jul; 27(7):1126-1139. PubMed ID: 29947256
[TBL] [Abstract][Full Text] [Related]
25. Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions.
Carrade DD; Affolter VK; Outerbridge CA; Watson JL; Galuppo LD; Buerchler S; Kumar V; Walker NJ; Borjesson DL
Cytotherapy; 2011 Nov; 13(10):1180-92. PubMed ID: 21899391
[TBL] [Abstract][Full Text] [Related]
26. Response to Intravenous Allogeneic Equine Cord Blood-Derived Mesenchymal Stromal Cells Administered from Chilled or Frozen State in Serum and Protein-Free Media.
Williams LB; Co C; Koenig JB; Tse C; Lindsay E; Koch TG
Front Vet Sci; 2016; 3():56. PubMed ID: 27500136
[TBL] [Abstract][Full Text] [Related]
27. Characterization and osteogenic potential of equine muscle tissue- and periosteal tissue-derived mesenchymal stem cells in comparison with bone marrow- and adipose tissue-derived mesenchymal stem cells.
Radtke CL; Nino-Fong R; Esparza Gonzalez BP; Stryhn H; McDuffee LA
Am J Vet Res; 2013 May; 74(5):790-800. PubMed ID: 23627394
[TBL] [Abstract][Full Text] [Related]
28. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients.
Sundin M; Ringdén O; Sundberg B; Nava S; Götherström C; Le Blanc K
Haematologica; 2007 Sep; 92(9):1208-15. PubMed ID: 17666368
[TBL] [Abstract][Full Text] [Related]
29. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
Poncelet AJ; Vercruysse J; Saliez A; Gianello P
Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
[TBL] [Abstract][Full Text] [Related]
30. The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses.
MacDonald ES; Barrett JG
Front Vet Sci; 2019; 6():507. PubMed ID: 32039250
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow-derived mesenchymal stem cells promote hepatic regeneration after partial hepatectomy in rats.
Li DL; He XH; Zhang SA; Fang J; Chen FS; Fan JJ
Pathobiology; 2013; 80(5):228-34. PubMed ID: 23614968
[TBL] [Abstract][Full Text] [Related]
32. Comparison of efficacy and safety of single versus repeated intra-articular injection of allogeneic neonatal mesenchymal stem cells for treatment of osteoarthritis of the metacarpophalangeal/metatarsophalangeal joint in horses: A clinical pilot study.
Magri C; Schramme M; Febre M; Cauvin E; Labadie F; Saulnier N; François I; Lechartier A; Aebischer D; Moncelet AS; Maddens S
PLoS One; 2019; 14(8):e0221317. PubMed ID: 31465445
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
[TBL] [Abstract][Full Text] [Related]
34. Canine and Equine Mesenchymal Stem Cells Grown in Serum Free Media Have Altered Immunophenotype.
Clark KC; Kol A; Shahbenderian S; Granick JL; Walker NJ; Borjesson DL
Stem Cell Rev Rep; 2016 Apr; 12(2):245-56. PubMed ID: 26638159
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
[TBL] [Abstract][Full Text] [Related]
37. Intravenous Administration of Bone Marrow-Derived Mesenchymal Stem Cell, but not Adipose Tissue-Derived Stem Cell, Ameliorated the Neonatal Hypoxic-Ischemic Brain Injury by Changing Cerebral Inflammatory State in Rat.
Sugiyama Y; Sato Y; Kitase Y; Suzuki T; Kondo T; Mikrogeorgiou A; Horinouchi A; Maruyama S; Shimoyama Y; Tsuji M; Suzuki S; Yamamoto T; Hayakawa M
Front Neurol; 2018; 9():757. PubMed ID: 30254603
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stem cells for treatment of musculoskeletal disease in horses: Relative merits of allogeneic versus autologous stem cells.
Colbath AC; Dow SW; McIlwraith CW; Goodrich LR
Equine Vet J; 2020 Sep; 52(5):654-663. PubMed ID: 31971273
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
Vet Comp Orthop Traumatol; 2013; 26(6):453-60. PubMed ID: 24080668
[TBL] [Abstract][Full Text] [Related]
40. Therapeutics prior to mesenchymal stromal cell therapy improves outcome in equine orthopedic injuries.
Bernardino PN; Smith WA; Galuppo LD; Espinosa-Mur P; Cassano JM
Am J Vet Res; 2022 Aug; 83(10):. PubMed ID: 35973004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
